| Reference |
|---|
Bean D, Liang Y, Avila F, He X, Asundi A, Sagar M. Endemic coronavirus infection is associated with SARS-CoV-2 Fc receptor-binding antibodies. J Virol. 2025;99:e0055025 pubmed publisher |
Li S, Ye F, Zheng Y, Wang J, Peng H, Zhu L, et al. Dual-Locking the SARS-CoV-2 Spike Trimer: An Amphipathic Molecular "Bolt" Stabilizes Conserved Druggable Interfaces for Coronavirus Inhibition. Adv Sci (Weinh). 2025;12:e2417534 pubmed publisher |
Verma S, Ana Sosa Batiz F, Timis J, Shafee N, Maule E, Pinto P, et al. Influence of Th1 versus Th2 immune bias on viral, pathological, and immunological dynamics in SARS-CoV-2 variant-infected human ACE2 knock-in mice. EBioMedicine. 2024;108:105361 pubmed publisher |
Cheng X, Shen H, Zhang W, Chen B, Xu S, Wu L. Characterizing the effects of triclosan and triclocarban on the intestinal epithelial homeostasis using small intestinal organoids. J Hazard Mater. 2024;479:135734 pubmed publisher |
Li Z, Obraztsova A, Shang F, Oludada O, Malapit J, Busch K, et al. Affinity-independent memory B cell origin of the early antibody-secreting cell response in naive individuals upon SARS-CoV-2 vaccination. Immunity. 2024;57:2191-2201.e5 pubmed publisher |
Sibille G, Mannino G, Frasson I, Pavan M, Luganini A, Salata C, et al. The Novel A-Type Proanthocyanidin-Rich Phytocomplex SP4™ Acts as a Broad-Spectrum Antiviral Agent against Human Respiratory Viruses. Int J Mol Sci. 2024;25: pubmed publisher |
Dos Santos Alves R, Timis J, Miller R, Valentine K, Pinto P, Gonzalez A, et al. Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice. Nat Commun. 2024;15:787 pubmed publisher |
Heo C, Lim W, Yang J, Son S, Kim S, Kim D, et al. Novel S2 subunit-specific antibody with broad neutralizing activity against SARS-CoV-2 variants of concern. Front Immunol. 2023;14:1307693 pubmed publisher |
Ravindran R, Kang H, McReynolds C, Sanghar G, Chang W, Ramasamy S, et al. Dynamics of temporal immune responses in nonhuman primates and humans immunized with COVID-19 vaccines. PLoS ONE. 2023;18:e0287377 pubmed publisher |
L xf3 pez Mu xf1 oz A, Santos J, Yewdell J. Cell Surface Nucleocapsid Protein Expression: A Betacoronavirus Immunomodulatory Strategy. bioRxiv. 2023;: pubmed publisher |
Anderson E, Li S, Awofolaju M, Eilola T, Goodwin E, Bolton M, et al. SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations. Cell Rep. 2022;41:111496 pubmed publisher |
Sun X, Yi C, Zhu Y, Ding L, Xia S, Chen X, et al. Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2. Nat Microbiol. 2022;7:1063-1074 pubmed publisher |
Chen Y, Tong P, WHITEMAN N, Moghaddam A, Zarghami M, Zuiani A, et al. Immune recall improves antibody durability and breadth to SARS-CoV-2 variants. Sci Immunol. 2022;:eabp8328 pubmed publisher |
Lanz T, Brewer R, Jahanbani S, Robinson W. Limited Neutralization of Omicron by Antibodies from the BNT162b2 Vaccination against SARS-CoV-2. Res Sq. 2022;: pubmed publisher |
Minervina A, Pogorelyy M, Kirk A, Crawford J, Allen E, Chou C, et al. SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8+ T cells. Nat Immunol. 2022;23:781-790 pubmed publisher |
Pattinson D, Jester P, Guan L, Yamayoshi S, Chiba S, Presler R, et al. A Novel Method to Reduce ELISA Serial Dilution Assay Workload Applied to SARS-CoV-2 and Seasonal HCoVs. Viruses. 2022;14: pubmed publisher |
Lederer K, Bettini E, Parvathaneni K, Painter M, Agarwal D, Lundgreen K, et al. Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals. Cell. 2022;185:1008-1024.e15 pubmed publisher |
Narowski T, Raphel K, Adams L, Huang J, Vielot N, Jadi R, et al. SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people. Cell Rep. 2022;38:110336 pubmed publisher |
Lin C, Wolf J, Brice D, Sun Y, Locke M, Cherry S, et al. Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response. Cell Host Microbe. 2022;30:83-96.e4 pubmed publisher |
Wratil P, Schmacke N, Karakoc B, Dulovic A, Junker D, Becker M, et al. Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses. Cell Rep. 2021;37:110169 pubmed publisher |
Shang Y, Chen F, Li S, Song L, Gao Y, Yu X, et al. Investigation of Interaction between the Spike Protein of SARS-CoV-2 and ACE2-Expressing Cells Using an In Vitro Cell Capturing System. Biol Proced Online. 2021;23:16 pubmed publisher |
Minervina A, Pogorelyy M, Kirk A, Allen E, Allison K, Lin C, et al. Convergent epitope-specific T cell responses after SARS-CoV-2 infection and vaccination. medRxiv. 2021;: pubmed publisher |
Ravindran R, McReynolds C, Yang J, Hammock B, Ikram A, Ali A, et al. Immune response dynamics in COVID-19 patients to SARS-CoV-2 and other human coronaviruses. PLoS ONE. 2021;16:e0254367 pubmed publisher |
Jennewein M, MacCamy A, Akins N, Feng J, Homad L, Hurlburt N, et al. Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects. Cell Rep. 2021;36:109353 pubmed publisher |
Klausberger M, Duerkop M, Haslacher H, Wozniak Knopp G, Cserjan Puschmann M, Perkmann T, et al. A comprehensive antigen production and characterisation study for easy-to-implement, specific and quantitative SARS-CoV-2 serotests. EBioMedicine. 2021;67:103348 pubmed publisher |
Natarajan H, Crowley A, Butler S, Xu S, Weiner J, Bloch E, et al. Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma. MBio. 2021;12: pubmed publisher |
Cho H, Gonzales Wartz K, Huang D, Yuan M, Peterson M, Liang J, et al. Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants. bioRxiv. 2021;: pubmed publisher |
Sakharkar M, Rappazzo C, Wieland Alter W, Hsieh C, Wrapp D, Esterman E, et al. Prolonged evolution of the human B cell response to SARS-CoV-2 infection. Sci Immunol. 2021;6: pubmed publisher |
Anderson E, Goodwin E, Verma A, Arevalo C, Bolton M, Weirick M, et al. Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection. medRxiv. 2020;: pubmed publisher |
Liu T, Hsiung J, Zhao S, Kost J, Sreedhar D, Hanson C, et al. Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates. Nat Biomed Eng. 2020;4:1188-1196 pubmed publisher |
Yu J, Yuan X, Chen H, Chaturvedi S, Braunstein E, Brodsky R. Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition. Blood. 2020;136:2080-2089 pubmed publisher |
Jiang Y, Tian M, Lin W, Wang X, Wang X. Protein Kinase Serine/Threonine Kinase 24 Positively Regulates Interleukin 17-Induced Inflammation by Promoting IKK Complex Activation. Front Immunol. 2018;9:921 pubmed publisher |
Yang M, Chen W, Zhang Y, Yang R, Wang Y, Yuan H. EphrinB/EphB signaling contributes to spinal nociceptive processing via calpain‑1 and caspase‑3. Mol Med Rep. 2018;18:268-278 pubmed publisher |
Frenkel M. [Charles Brenton Huggins, co-winner of the Nobel Prize in physiology and medicine, 1966]. Ned Tijdschr Geneeskd. 1966;110:1994-5 pubmed |
